Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

3rd Feb 2009 09:41

RNS Number : 6924M
PuriCore Plc
03 February 2009
 



Directors' Dealings

 PuriCore Directors Acquire Shares in the Company

MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 February 2009 - PuriCore (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announces that on 2 February 2009 the following Directors purchased shares in the Company, as set out below:

Name

Number of shares purchased

Purchase Price of shares

Total number of shares held

% of issued share capital

Director

James Walsh

180,000

5.125p

500,000

.23%

Joseph William Birkett

440,000

5.500p

540,000

.25%

Enquiries:

Ben Brewerton 

Greg Bosch, CEO

Susan Quigley

Darren Weiss, VP, Finance

Financial Dynamics

PuriCore

+44 (0) 20 7831 3113

+1 484 321 2700

About PuriCore

PuriCore plc (LSE: PURI) is a life sciences company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore's patented, proprietary technology mimics the human body's production of the natural antimicrobial hypochlorous acid, offering a safe and non-hazardous approach to disinfection and sanitisationThe Company's products are used in a broad range of markets that depend upon controlling contamination, including retail and foodservice, medical device disinfection, and wound care. Hypochlorous acid is proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of M. tuberculosis, MRSA, E.coli, Norovirus, H5N1 Avian Influenza, HIV, Salmonella, Polio Virus, Helicobater pylori, and Legionella. PuriCore is headquartered in Malvern, Pennsylvania, with offices in Stafford, UK. 

To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUUUUCPUPBUBW

Related Shares:

RLM.L
FTSE 100 Latest
Value8,275.66
Change0.00